PROFESSOR KEVIN WHELAN
Kevin Whelan is the Professor of Dietetics and Head of Department of Nutritional Sciences at King’s College London. His research investigates the interaction between diet and the gut microbiome in health and disease, including in inflammatory bowel disease and irritable bowel syndrome.
He has published over 200 journal articles on fibre, probiotics, prebiotics, protein, the low FODMAP diet and emulsifiers. Kevin advises the UK government as a member of the Scientific Advisory Committee on Nutrition. In addition, he is a Founding Trustee of the Academy of Nutrition Sciences and on the editorial board of the Journal of Human Nutrition and Dietetics.
In 2012 he was awarded the Nutrition Society Cuthbertson Medal for clinical nutrition, in 2017 was appointed a Fellow of the British Dietetic Association and in 2018 delivered the Dr Elsie Widdowson Memorial Lecture.
Andrew Denton is a writer and broadcaster who has worked in every medium except
crayon. He counts Rupert Murdoch, Paul Keating and Germaine Greer amongst his favourite detractors. He is also the founding director of Go Gentle Australia, a national advocacy organisation that has played a critical role in the introduction of voluntary assisted dying laws.
STEVE VAN APEREN
Steve van Aperen is an author, speaker, media commentator and trainer. He is known as an expert in the field of behavioural interviewing, reading body language, detecting deception and changing behaviours through rapid induction hypnosis. He can hypnotise most people in less than 5 seconds! He has also conducted behavioural interviews on 78 homicide and 2 serial killer investigations and consults his services to fortune 500 companies, police departments, intelligence agencies and government departments throughout the world.
Steve has appeared on CNN, Access Hollywood, The News Room and many other programs and is affectionately referred to as the “The Human Lie Detector”.
As a former police officer having trained with the FBI, LAPD and the US Secret Service he has emerged as a leading authority on reading and analysing human behaviour. Today Steve devotes his knowledge to helping businesses and individuals thrive by changing behaviours, improving human rapport, building trust and reading their clients.
Today Steve will show you why his friends never lie to him about their golf scores!
PROFESSOR TRACIE BARBER
Professor Barber is a researcher in Mechanical Engineering at The University of New South Wales, Sydney Australia. Her research centres on a combination of computational and experimental fluid dynamic techniques to solve clinical and industrial problems, primarily in the field of vascular and microfluidics flow.
She has over 250 refereed publications across both biomedical and fluid mechanics journals, is the first woman Fellow of the Australasian Fluid Mechanics Society, has two teenage children, two dogs who act like teenagers, and she spends a lot of time at the beach.
Amanda Luke has worked in Renal Nursing for the last 23 years. She has worked in many different roles but has found her true passion in the field of Renal Vascular Access and has been in the Nurse Consultant role at Flinders Medical Centre for the last 6 years. She is very passionate about the ‘fistula first’ model of care and has been leading the way in the Southern Hemisphere when it comes to the Endovascular AVF creation program started at FMC in 2022.
She is always striving to improve vascular access for patients and staff alike and is always happy to share her skills and knowledge with her colleagues.
Paul Robertson is the current president of the Australian Donation & Transplant Co-ordinators Association (ADTCA)
Paul has been involved in organ donation and transplantation roles within Australia for the past 30years. His primary role is as the Transplant Co-ordinator for the Pancreas Transplant program @ Westmead Hospital.
Paul has past experience as a critical care nurse, Donor co-ordinator and recipient co-ordinator. He has a Law degree and as such has a very strong interest in legislation governing donation/transplantation and the mechanisms of organ allocation.
Paul has a long career in managing renal and pancreas transplant waiting lists with a particular interest in equity and patient access to transplantation.
Marguerite Conley, MNutDiet, Bsci (ExSportSci) is a Senior Clinical and Kidney Research Dietitian at the Princess Alexandra Hospital and PhD Candidate at Queensland University of Technology, Brisbane Australia. Her research interests are in the delivery of lifestyle interventions for the management of obesity in patients with kidney disease
Elizabeth is the Renal Access Coordinator at the Toowoomba Hospital, Darling Downs Health, Queensland. She has worked in all areas of Renal Dialysis since 1994 and as the Renal Access Coordinator since 2009.
Elizabeth has participated as speaker / facilitator at the Renal Society of Australasia Vascular Access Workshops, Vascular Access Webinar, and the QLD education symposium. She has co-facilitated the biannual joint Toowoomba / Gold Coast Renal Access Workshop since 2017 and has been an active member of the ANZSIN Group from 2016 to 2021 and past committee member of ANZSNCIN.
She is passionate about improving dialysis access outcomes and sharing her knowledge of vascular access.
DR MARK PENNY
Dr Mark Penny is a nephrologist at St Vincent's Private Hospital Sydney, specialising in hypertension and kidney disease. Dr Penny has special interest in general nephrology, chronic kidney disease, hypertension and nephritis.
Dr Penny is an experienced researcher and serves as Conjoint Senior Lecturer in Medicine at the University of Notre Dame. Dr Mark Penny is also the medical director at Life First, which provides tailored health assessments.
His current appointments include: Senior Staff Specialist, Nephrology, St Vincent's Hospital, Sydney, Head of Department, Nephrology & Hypertension, St Vincent's Clinic & Private Hospital, Sydney, Chairman, Drug Committee, St Vincent’s Private Hospital, Sydney and Conjoint Senior Lecturer in Medicine, University of Notre Dame.
Jacqui Moustakas is the Renal Nurse Practitioner at of Satellite and Home Therapies for the Sydney Local Health District. Jacqui became endorse as an NP in December 2017. Jacqui is a nurse leader and role model in patient centred care. She is passionate about improving lives of patients on dialysis.
DR JAMES McVEIGH
Mr. James McVeigh is an authorised Nurse Practitioner within the specialty field of cardiology.
Qualified as a Registered Nurse (RN) in 1988 in Belfast in Northern Ireland and immigrated to Australia in 1992.
Commenced employment in Australia as an RN in the Coronary Care Unit at Royal Prince Alfred Hospital Sydney and since that date has been employed by a number of the large tertiary referral hospital in Sydney (St Vincent’s & Prince of Wales) until today.
Also worked in nursing academia from 1998-2001 as the Cardiac Specialists Educator at then NSW College of Nursing.
Commenced current employment at Prince of Wales Hospital (POWH) in Sydney in 2001 and responsible for the development and delivery of the Heart Failure service. Authorised as a Nurse Practitioner (specialized in cardiology practice) in 2003 to enhance outcomes and provide a flexible management approach for people living with chronic heart failure.
Research activities include: principle POWH site investigator for the Which Heart failure Intervention is most Cost-effective in reducing Hospital stay (WHICH II) trial 2013- 2016 and Co –investigator on “Total Cardiac Care” – pilot study at POWH (2019-2020) a randomized mobile phone app providing tele monitoring for the management of ACS & HF.
Current academic appointments at Sydney University and UTS nursing departments as an associate lecturer. He was an original content expert for Heart-Online, (www.heartonline.org.au) an online educational resource to assist in the management of Heart Failure and cardiac rehabilitation
Foundation fellow of the Australian College of Nurse Practitioner
Past President and Life Member of Australasian Cardiovascular Nursing College
Carla Scuderi BPharm M Clin Pharm Phd (candidate)
Carla Scuderi a pharmacist with over 20 year’s experience is the Pharmacist Team Leader for the Kidney Health Service based at Royal Brisbane and Women's hospital and a former course coordinator in the University of Queensland Post graduate Clinical Pharmacy Program. Carla is currently the co-chair of the Society of Hospital Pharmacists Nephrology special interest group and is a member of the CARI guidelines steering committee and Kidney Health Australia clinical advisory committee.
Her previous roles include being a community pharmacy manager and owner, a Quality Use of Medicine facilitator for the National Prescribing Service and GP and pharmacist clinical educator. Carla's is currently undertaking a PhD investigating microsampling and the pharmacist’s role in kidney transplants. Carla’s a passionate advocate for patient centered care.
PROFESSOR RACHAEL WALKER
Professor Rachael Walker is an academic Nurse Practitioner in Hawke’s Bay, New Zealand. Rachael’s research interests include: improving equity in kidney disease, particularly in Indigenous peoples, remote patient monitoring, patient preferences and patient reported experiences and outcomes and health service policy.
Rachael is on a number of national and international boards including the ISN Kidney Health Professional Working Group, International Society of Peritoneal Dialysis Scholarships and Awards Committee, Australasian Kidney Trials Network. Rachael has published a number of articles on patient and family experiences of kidney disease and has been part of Indigenous consultation and guideline writing of the first CARI Guidelines for care of Indigneous people with kidney disease in New Zealand.
DR BRENDON NEUEN
Dr Brendon Neuen is a Staff Specialist Nephrologist, Director of the Kidney Trials Unit at Royal North Shore Hospital and Senior Research Fellow at The George Institute for Global Health. .
He is an internationally recognised expert on the efficacy and safety of SGLT2 inhibitors and serves as the founding Secretariat of the SGLT2 Meta-Analysis Cardio-Renal Trialists' Consortium (SMART-C). His work has directly informed more than 25 major international and national clinical practice guidelines, position papers and scientific statements which define best practice for the care of people with type 2 diabetes and kidney disease, including the Kidney Disease Improving Global Outcomes (KDIGO) Guidelines and the American Diabetes Association (ADA) Standards of Care.
Lynn started nursing in 1981 in England. She worked in Nephrology and Intensive Care there until 2004, when she migrated to Australia, where she has worked in a range of clinical, education and management renal roles in WA and NSW. She now works as a Treatment Support Nurse providing education and support for patients with chronic diseases.
An RSA member since 2004, she has been a branch education officer, conference convenor, NEN treasurer, and brand ambassador for EDTNA. She joined the RSA board of directors in 2022.
Lynn remains passionate about nurse education and believes continuing education for all renal nurses is vital to enable best possible care for patients with kidney disease.
DR MONICA SCHOCH
Monica is a Senior Lecturer in School of Nursing & Midwifery at Deakin University. Her clinical area of interest/research is in renal vascular access, use of plastic cannula, and she has completed her PhD on use of point-of care ultrasound for guided cannulation in haemodialysis. Monica was on the executive committee of the Nephrology Educators Network for 10 years where she led teams to build internationally renowned vascular access and buttonhole cannulation E-learning modules. She was also the national coordinator of the Vascular Access workshops for the Renal Society of Australasia from 2017 to 2020.
Kay McLaughlin is a Mātanga Tapuhi/nurse practitioner working in the renal service at Capital, Coast and Hutt Valley, Te Whatu Ora Health New Zealand. She has worked in renal healthcare for more than 35 years in a variety of nursing roles in Australia and New Zealand including education, management and as a clinical nurse specialist. She completed her master’s degree at Victoria University, Wellington and postgraduate studies in health science at Auckland University. Kay became a nurse practitioner in July 2022 and works with patients and whanau across the CKD spectrum. She has been a committed member of the RSA all of her career and enjoys the opportunity to work with colleagues to advance care for people with chronic kidney disease.
Jayson is a Clinical Nurse Consultant for Dialysis Access at a large tertiary teaching hospital in Sydney. Jayson is a seasoned haemodialysis clinician with over 13 years of renal nursing experience locally and internationally. He is also a Research Coordinator in Fresenius Kidney Care, Australia & New Zealand, a global kidney service provider. His expertise includes vascular access coordination, vein preservation and point-of-care ultrasound use in arteriovenous access cannulation. As a lecturer and facilitator for nursing students, Jayson is dedicated to advancing the field of renal nursing through evidence-based practice and innovative approaches. His multifaceted role allows him to contribute to the field from multiple perspectives, driven by his passion for optimising patient outcomes.
Jodie Mitchell has spent 28 years working as a passionate renal nurse, commencing her career in 1995 as an Enrolled Nurse working at St. George Hospital, later graduating as a registered nurse. Much of her career was spent working for Illawarra Shoalhaven LHD where she gained extensive experience in all renal modalities. Currently she is the Renal Nurse Unit Manager in the Eurobodalla SNSWLHD.
She has Graduate Diploma’s in renal nursing and leadership and is currently undertaking her Masters in Nursing Leadership. Jodie is an active RSA member and is on the ACI Water for Dialysis working group.
Richard Modderman is a senior physiotherapist at Sunshine Coast University Hospital in QLD and associate lecturer at Flinders University in Darwin, Northern Territory. His research involvement has focused on translational approaches for improving clinical practice and patient centred care through Physiotherapy, including the spectrum of emergency care through to chronic disease management. He has particular interest in patient-important management of frailty in people with chronic kidney disease, and the value of multidisciplinary care in sustainable healthcare reform.
PROFESSOR PETER KERR
Professor Peter Kerr graduated from Monash University in 1980. He trained in Nephrology at Prince Henry’s Hospital and Austin Hospital, Melbourne and achieved his PhD in transplant immunology at Prince Henry’s Hospital under Bob Atkins.
In 1991, Prof. Kerr decided to focus on haemodialysis, working with Charles Mion and Angel Argiles in Montpellier, France. Since then, he has been involved in haemodialysis at a clinical, research, teaching and administrative level.
Prof. Kerr has been involved in a large number of clinical trials, including company trials, local investigator initiated trials and national trials networks. On-going research interests of his include dialysis access, nutrition in CKD and dialysis, bone and mineral metabolism, cardiovascular disease and vascular calcification in renal patients.
Prof. Kerr has been an active member of the Scientific Advisory Board for the Australian Nephrology Clinical Trials Network, the Council of the International Society of Nephrology and the Asian Pacific Society of Nephrology. He is current Treasurer of the Australian and New Zealand Society of Nephrology. He was Editor in Chief of the journal “Nephrology” for 8 years and was Chair of the Organising Committee for the World Congress of Nephrology in Melbourne, 2019.
Since 2006, Prof. Kerr has been Professor and Director of the Department of Nephrology at Monash Medical Centre in Melbourne, Australia.
ASSOCIATE PROFESSOR RIA ARNOLD
Associate Professor Ria Arnold PhD is an Accredited Exercise Physiologist (AEP) and Academic at the University of Wollongong and holds an appointment with as a practicing AEP with the Renal Department at Concord Repatriation General Hospital. She is the co-director of the Kidney Lifestyle Research Group at UOW with A/Prof Kelly Lambert leading a program of research focused on scalable lifestyle interventions to improve health and wellbeing outcomes for people with kidney disease. She is the Chair of the Research Committee for Exercise & Sports Science Australia (ESSA), the national governing body for exercise and sport science professionals and a member of the Global Renal Exercise Network.
DR TERESA TOWPIK
Dr Towpik has been a General Practitioner in Australia since 1993 and an advocate of medicinal cannabis since the law was amended and cannabis was legalised for medicinal use. Since then she has been studying the therapeutic properties of cannabis, how it works in the human body and the potential applications in General Practice, especially in the management of chronic debilitating pain.
In 2016, Dr Towpik founded MediHuanna, an organisation that provides science-based medicinal cannabis education for Health Professionals.
Dr Towpik has been prescribing medicinal cannabis for various clinical conditions, including chronic pain, PTSD, autism, epilepsy, depression, anxiety since March 2018 and she has observed some very significant positive results.
She has published a 2nd edition of Introduction to medicinal cannabis in May 2019, in which she is sharing her prescribing experience, basic cannabis science, clinical conditions, patient’s care and monitoring.
Dr Towpik sees cannabis as a therapeutic agent that has huge potential in General Practice. Her goal is to change the stigma of cannabis through education, enabling it to be seen as an important medicine that should be integrated into modern medicine to be used with other modalities of healing.
DR RIONA PARIS
Dr Riona Pais is a Palliative Medicine Staff Specialist, also the lead in training and research at Royal Prince Alfred (RPA) Hospital. In addition, she leads the Renal Supportive Care (RSC) Service here. Dr Riona Pais is an executive tertiary/teaching hospital representative committee member of the RSC (NSW) division, member of the RSC Special interest group of the ANZSPM, Palliative Care Clinical Studies Collaborative and Clinical Senior Lecturer at the University of Sydney. She is currently running studies looking at the safety and efficacy of drugs in End stage kidney disease.
Dr Riona Pais is research supervisor to MD and MPhil students at the University of Sydney and is PI to studies in RSC that include evaluating Experience of patients with End Stage Kidney Disease (dialysis and conservative pathway) referred to the Renal Supportive Care Service. She is the recipient of the 2022 International Rosalind Franklin award for the best paper in a palliative medicine journal for her research in Palliative care.
PROFESSOR ANN BONNER
Prof Ann Bonner PhD, RN, has over 30 years’ experience in nephrology practice, education and research. Her program of research spans the trajectory of chronic kidney disease with a particular focus on health literacy, symptom management, self-management, health service innovation, and advanced practice nursing roles. She has attracted NHMRC research funding and has over 180 publications.
Ann is a life-member of the Renal Society of Australasia, a member of the Australian Institute of Health and Welfare (AIHW) Chronic Kidney Disease Expert Advisory Group, and in 2021 was inducted into the International Nurse Researcher Hall of Fame.
ASSOCIATE PROFESSOR SHILPA JESUDASON
Associate Professor Shilpa Jesudason (MBBS, PhD, FRACP) is an academic nephrologist and Chair of the Clinical Research Group at the Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service (CNARTS). Her clinical and research interests include Parenthood in Patients with Kidney Disease. She is the founder and Program lead of the research group, Pregnancy and Kidney Research Australia. She runs a state-wide obstetric nephrology service for preconception counselling, antenatal and postnatal care for women with all stages of CKD in pregnancy. Her research program employs a broad array of methodologies (population data linkage, registry, cohort studies, qualitative, systematic reviews, basic science) to investigate parenthood outcomes and best care for women and men with renal disease.
Shilpa is the immediate past Clinical Director of Kidney Health Australia (2017-20) and co-led the development and delivery of the National Strategic Action Plan for Kidney Disease, the KHA Youth Program State of the Nation report and National Consensus Statement for the Care of Youth with CKD, and the KHA Yarning Kidneys Indigenous Consultations program. She has expertise in consumer and community engagement for kidney disease research, policy and advocacy.
DR BRENDAN SMYTH
Dr Smyth is nephrologist at St George Hospital, Sydney, Australia. He completed his PhD in 2020, investigating randomized controlled trial methods and implementation in haemodialysis. His interests are in improving dialysis care, symptom management, and increasing participation in randomized research in nephrology. He has led the development of the ISN Clinical Trials Toolkit and Global Trials Focus and he is an ISN Emerging Leader for 2022-23. He has multiple publications and has contributed textbook chapters, is on the editorial board of the journal Kidney Blood Pressure Research, and reviewer for journals including NDT and JASN.
Brendan now works as a post-doctoral fellow at the NHRMC Clinical Trials Centre, University of Sydney, where he has leadership roles in a number of innovative trials in dialysis, including a pilot study of the use of cannabidiol (medicinal cannabis extract) in people with symptoms associated with kidney failure.
ASSOCIATE PROFESSOR MATTHEW ROBERTS
A/Prof Matthew Roberts, Deputy Director of Nephrology, Eastern Health
A/Prof Roberts is a full-time Nephrologist at Eastern Health in Melbourne and Adjunct Associate Professor in the Eastern Health Clinical School, Monash University. He is the current Chair of the Australasian Kidney Trials Network (AKTN) Scientific Committee and past Chair of the AKTN Haemodialysis Work Group.
He is on the Trial Management Committee for the Incremental dialysis to improve Health outcomes in people starting Haemodialysis (INCH-HD) study. He is Chair of the Haemodialysis Work Group for the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, and Chair of the Cochrane Kidney and Transplant Advisory Board.
DR TERESA NICOLETTI
Dr Teresa Nicoletti is a partner at Mills Oakley Lawyers and is Head of their Health and Life Sciences practice. She is both a lawyer and PhD-qualified scientist with 30 years’ experience in the health and life sciences sector in Australia, having advised clients across the pharmaceutical, medical device, food and cosmetics industries in Australia and New Zealand. She is a recognised leader in her field and is particularly regarded as Australia’s leading expert in the regulation of therapeutic goods, cosmetics, medicinal cannabis and hemp. In 2016, Teresa won the inaugural Lawyers Weekly Partner of the Year award for Health and took out the same award in 2017 and 2022. She has also been listed in Best Lawyers Biotechnology, Life Sciences, and Health and Aged Care categories for the past five years, is the only Australian lawyer listed in the Global Top 200 cannabis lawyers and has obtained the highest possible Band 1 ranking in the Life Sciences Category in Chambers Asia Pacific for the past 6 years.
In addition to her role at Mills Oakley, Teresa is a part-time senior member of the Administrative Appeals Tribunal, a position she has held since August 2006, and is a founding Board member of the Australian Medicinal Cannabis Association.
Carla is a social worker currently employed as a clinical specialist at John Hunter Hospital, Newcastle, NSW. Carla has a professional background working in renal dialysis, renal supportive care, immunology and infectious disease, and general medicine.
Carla has an interest in mental health, dementia, promoting shared decision making for patients and advance care planning.
Lucy Spencer started her career in renal nursing over 35 years ago in Canberra and since then has had a career that has included both clinical and management roles, predominantly within the field of haemodialysis.
She is currently a nurse practitioner in the haemodialysis units at Royal North Shore Hospital in Sydney.
DR MARGARET FRANKEL
Dr Margaret Fraenkel trained in Nephrology and General Medicine in South Australia and moved to Melbourne to undertake a PhD. She was Full time Nephrologist at Austin Health in 1994, leaving in 2011 to work at Eastern Health. She is Medical Director of the Dialysis Unit at Epworth Eastern Hospital and a VMO at Eastern Health.
Her interests include management of Chronic Kidney Disease, prevention of vascular complications, timely preparation for dialysis and renal transplantation, providing best quality of life for those with deteriorating renal function and preparation for end of life care.
She completed her training in Voluntary Assisted Dying (VAD) in Victoria shortly after VAD was available to the Victorian Public and has now been involved in over 40 patients, both as Coordinating and Consulting Practitioner.
Helen Hoffman RN (comp), PG Dip Nursing, RN Prescriber, Bachelor of Arts: Anthropology
Clinical Nurse Specialist, Renal Service, Wellington Hospital, NZ.
Margaret has worked in the area of renal nursing for 30 years and enjoys the clinical challenges inherent in working with this complex patient group.
Her current CNS role incorporates education and assessment for renal replacement therapy and the coordination of all dialysis access. In the education and assessment of patients regarding their treatment options, a key aspect of my role is supporting the patient and whanau to make the best decision for their situation and for some this will be a conservative approach. The introduction in Aotearoa of the End of Life choice Act 2019 has introduced a whole new ethical discussion that I believe renal healthcare professionals need to be part of. Some of the patients I see do want to discuss this option and this can present challenging conversations.
Helen has an interest in the area of renal supportive care for these patients and in the challenges these difficult conversations can entail and was part of a team of renal and palliative healthcare professionals who developed a renal specific multi-disciplinary communications skills training program to address concerns about undertaking these difficult conversations. The “Communication Skills initiative in Nephrology” or CSI-Nephro was based on the premise that communication skills can be learned. She was also a participant on one of the courses.
Victoria was the first state in Australia to introduce voluntary assisted dying. Susan is a clinical nurse consultant and manager of the Victorian VAD navigator service, having been with the team since inception in 2019. The navigator service provides information and support to anyone wanting information about, access to, or impacted by voluntary assisted dying – individuals, families, clinicians and health services, both supportive and non-supportive. This includes around 1,000 individuals or families a year.
Susan has an extensive health program development background and a master’s degree in public health.
Lenny first entered the world of renal nursing as a graduate RN in 2006 where she discovered the joy and challenges of CKD, from peritoneal dialysis to transplantation through to end of life care. At 26 years, she became one of the youngest Clinical Nurse Specialists on the renal ward.
Outside of work, Lenny founded a charity in 2016, The Essentials Collective Inc, to provide essential toiletries and underwear for homeless and disadvantaged people in Perth. This has seen her become a Westfield Local Hero in 2020 and Citizen of the Year in 2021 in her home town of Victoria Park, WA.
DR BRONWYN HAYES
Dr Bronwyn Hayes has been a renal nurse since 1998 working in haemodialysis and transplantation where her main focus has been on providing evidence-based health care to Aboriginal and Torres Strait Islanders, particularly those who live in remote locations. She has been instrumental in improving the access to transplantation for patients in remote Far North Queensland. While this position is predominately clinical, Bronwyn also has an interest in undertaking research.
In 2015 Bronwyn completed her Doctorate looking at job satisfaction, stress and burnout in haemodialysis nurses and more recently looking at transplant specific research topics. Bronwyn is involved in national and state renal and transplant committees and is also chair of the RSA Conference Committee.
Suzanne Waldron is a behavioural change facilitator, interviewer and curator. Working globally with influential leaders, her focus is on embedding healthy relationships within ethical systems. For business, community and culture. She's an active ambassador for RUOK?, Nakuru Hope, she’s a Creative Director for Museum of Freedom and Tolerance, former curator for TEDx. A twice published author, Suzanne has also been nominated for Western Australian of the Year for her community work.
Alan Hoffmeister is the Senior Global Technology and Market Development Manager for Charles River, Microbial Solutions Division, specialising in the Bacterial Endotoxins Test.
Alan’s experience with the Bacterial Endotoxins Test (BET) dates to 1988, since when he has been actively involved in all aspects of the assay. Alan has directed workshops and training courses and lectured internationally on a variety of BET topics including, amongst others, LAL Methodologies, Product Validations, Interference Matrices, Data Integrity and BET Regulatory Affairs. He has also contributed to the development of BET protocols, technical guides and fact sheets internally as well as for clients and industry organisations
Sally is a registered nurse who has had over 40 years’ experience in the field of nephrology in Australia, New Zealand and Asia-Pacific. She has a passion for renal access and stives to impart her years of knowledge to ensure patient outcomes are optimal.
Sally has provided global support for the Argyle Fistula cannula since commencing working with Medtronic in 2016. Still a practicing haemodialysis nurse, Sally is able to provide in depth knowledge and practical solutions to the challenges of introducing this technology into the participants service.